Vitamin K and Improved Objective Response Rate

• Anticancer effects of vitamin K combined with transarterial chemoembolization in hepatocellular carcinoma, a randomized controlled trial.

  • 2025-04-22
  • RCT · n = 51
  • British journal of cancer 132(12)
  • • Yoshimichi Haruna
    • Takayuki Yakushijin
    • Miho Yamakawa
    • Tetsuo Nakazawa

  • PubMed: 40263401
  • DOI: 10.1038/s41416-025-03022-4

  3 Insights on

  • Improved Objective Response Rate

  • High evidence
  • Clinical

  The TACE + vitamin K group (n = 50) exhibited a significantly higher objective response rate than the TACE alone group (n = 51) (96.0% vs. 82.4%, p = 0.028).

  Effect

  Beneficial

  Effect size

  Moderate

  Significant

  Yes